The Censeo online mental health assessment has been built by Psyomics Ltd. The technology evolved from a large-scale clinical trial conducted by the Cambridge Centre of Neuropsychiatric Research (CCNR), looking into early and accurate mental health diagnosis. As a result of this ground-breaking research, the Censeo diagnostic algorithm has since been refined and the assessment expanded to include a greater number of key mental health conditions.
Psyomics is developing unique technology to radically improve the way mental health conditions are assessed and triaged. Drawing on both psychiatric and psychological expertise, our digital diagnostic tools provide every patient immediate access to a complete mental health review.
Our aim is to revolutionise the way mental health conditions are identified and diagnosed, increasing clinical capacity and helping patients to access the right level of support, first time, every time.
Psyomics was co-founded by Professor Sabine Bahn, head of the Cambridge Centre for Neuropsychiatric Research (CCNR) and Daniel Cowell, former COO of Horizon Discovery, with the goal of improving diagnosis of neuropsychiatric disorders. The company is supported by Cambridge Enterprise, Innovate UK, Parkwalk and European Commission’s Horizon 2020 programme.